Kim Witczak

Kim Witczak is a globally recognized drug safety advocate whose activism began after the sudden death of her husband from undisclosed side effects of an antidepressant. Her advocacy helped lead to the addition of the FDA’s black box suicide warnings on antidepressants.

With over 25 years in advertising and marketing, Kim brings a unique perspective to FDA reform, transparency, and patient safety. She co-founded the nonprofit Woodymatters and served three terms as the Consumer Representative on the FDA’s Psychopharmacologic Drugs Advisory Committee. Kim also co-organized the international Selling Sickness: People Before Profits conference and serves on multiple patient advocacy boards, including USA Patient Network, Inner Compass, Conscious Clinician Collective, and MISSD (Medication-Induced Suicide in Memory of Stewart Dolin).

Through her work, Kim amplifies the voices of patients and families, advocating for accountability, informed consent, and a more transparent healthcare system.